GSK plc ADRhedged ETF (GSKH) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with GSKH. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to GSKH
GSKH charges 0.19% annually. There are 4 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.08%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| Fidelity MSCI Health Care Index ETF | 0.08% | 3.22B | Oct 2013 | GSKH vs FHLC | |
| State Street Health Care Select Sector SPDR ETF | 0.08% | 41.65B | Dec 1998 | GSKH vs XLV | |
| Vanguard Health Care ETF | 0.09% | 19.00B | Jan 2004 | GSKH vs VHT | |
| Portfolio Building Block World Pharma and Biotech ... | 0.13% | 951.16M | Nov 2025 | GSKH vs PBPH | |
| Invesco Nasdaq Biotechnology ETF | 0.19% | 74.65M | Jun 2021 | GSKH vs IBBQ |
Best Risk-Adjusted Alternatives to GSKH
GSKH has a PortfoliosLab risk / return rank of 54. There are 33 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 96.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 96 | 57.56M | Dec 2014 | GSKH vs BBC | |
| ALPS Medical Breakthroughs ETF | 94 | 213.08M | Dec 2014 | GSKH vs SBIO | |
| First Trust Nasdaq Pharmaceuticals ETF | 94 | 36.36M | Sep 2016 | GSKH vs FTXH | |
| iShares U.S. Pharmaceuticals ETF | 93 | 1.34B | May 2006 | GSKH vs IHE | |
| SPDR S&P Biotech ETF | 93 | 11.10B | Feb 2006 | GSKH vs XBI |
Top Performing GSKH Alternatives (YTD)
GSKH is at 9.01% YTD. There are 28 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 41.35%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 41.35% | 44.37M | Sep 2021 | GSKH vs PSIL | |
| ARK Genomic Revolution Multi-Sector ETF | 38.38% | 1.31B | Oct 2014 | GSKH vs ARKG | |
| Roundhill UNH WeeklyPay ETF | 31.46% | 6.01M | Dec 2025 | GSKH vs UNHW | |
| Virtus LifeSci Biotech Clinical Trials ETF | 29.44% | 57.56M | Dec 2014 | GSKH vs BBC | |
| SPDR S&P Health Care Services ETF | 26.76% | 204.10M | Sep 2011 | GSKH vs XHS |
Lowest Volatility Alternatives to GSKH
GSKH has 26.55% 1-year volatility. There are 56 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 0.00%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Loncar Cancer Immunotherapy ETF | 0.00% | 12.73M | Oct 2015 | GSKH vs CNCR | |
| Amplify Treatments, Testing and Advancements ETF | 0.00% | 9.68M | Jun 2020 | GSKH vs GERM | |
| Horizon Kinetics SPAC Active ETF | 8.62% | 10.11M | Jun 2007 | GSKH vs SPAQ | |
| State Street Health Care Select Sector SPDR Premiu... | 11.06% | 16.78M | Jul 2025 | GSKH vs XLVI | |
| Milliman Healthcare Inflation Plus ETF | 11.54% | 982.35K | Apr 2026 | GSKH vs MHIP |
Lowest Drawdown Alternatives to GSKH
GSKH has a 1-year max drawdown of -18.54%. There are 48 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as 0.00%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | 9.68M | Jun 2020 | GSKH vs GERM | |
| Horizon Kinetics SPAC Active ETF | -4.32% | 10.11M | Jun 2007 | GSKH vs SPAQ | |
| First Trust Nasdaq Pharmaceuticals ETF | -7.47% | 36.36M | Sep 2016 | GSKH vs FTXH | |
| Invesco Nasdaq Biotechnology ETF | -8.34% | 74.65M | Jun 2021 | GSKH vs IBBQ | |
| iShares U.S. Pharmaceuticals ETF | -8.47% | 1.34B | May 2006 | GSKH vs IHE |
Other ETFs from ADRhedged
The 5 most viewed ADRhedged ETFs shown here include STHH, TMH, HSBH and span 6 categories. AUM among these funds goes as high as $8M.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| STMicroelectronics NV ADRhedged | Technology Equities | 68 | 148.48% | 7.89M | Mar 2025 | GSKH vs STHH | |
| Toyota Motor Corporation ADRhedged | Consumer Discretionary Equities | — | — | 1.16M | Mar 2025 | GSKH vs TMH | |
| HSBC Holdings plc ADRhedged ETF | Financials Equities | 91 | 30.58% | 5.04M | Oct 2024 | GSKH vs HSBH | |
| ADRhedged SAP ETF | Actively Managed, Technology Equities | 1 | -29.61% | 324.50K | Jan 2025 | GSKH vs SAPH | |
| Shell plc ADRhedged ETF | Energy Equities, Global Equities | 35 | 16.83% | 2.63M | Oct 2024 | GSKH vs SHEH |
Often Compared With GSKH
Investors most often compare GSKH with PJP, BMED, BBP. These 20 comparison targets span 4 categories, based on PortfoliosLab usage data.
Compare GSKH with Any Fund or Stock
Compare GSKH with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair GSKH with funds that move differently
GSK plc ADRhedged ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to GSKH.
Explore GSKH Diversifiers